Key result
High-intensity statins in aortic stenosis linked to ~30% more valve-related hospitalizations and increased calcification.
Why the study?
Statins are known to influence PCSK9 production, which is linked to calcification, but their relationship with aortic valve calcification in aortic stenosis warrants investigation.
Does high-intensity statin therapy increase aortic valve calcification and hospitalization in patients with severe aortic stenosis?
Observational
Does high-intensity statin therapy increase aortic valve calcification and hospitalization in patients with severe aortic stenosis?
High-intensity statin therapy may paradoxically promote aortic valve calcification and worsen clinical outcomes in patients with severe aortic stenosis, potentially mediated by increased PCSK9 secretion.
Answers are grounded in this paper and cite their sources.
Caution advised with high-intensity statins in aortic stenosis; hypothesis-generating for accelerated valve disease and needs randomized confirmation.
Aortic stenosis (AS) is the most common valvular disease, characterized by progressive fibro-calcific remodeling of the aortic leaflets, leading to increased morbidity and mortality. It is now well known that statins influence the production of proprotein convertase subtilisin/kexin type 9 (PCSK9), which in turn is linked to calcification. Here, we found that statins significantly increased, in a dose dependent manner, both PCSK9 secretion and valve interstitial cell (VIC) calcification, in vitro. These effects were blunted by PCSK9 genetic knock-down or by PCSK9 antibody neutralization. In AS patients, contrast-enhanced computed tomography evaluation showed a higher aortic valve calcium (AVC) content in patients on high-intensity statins compared to low-intensity ones, with no significant difference between low-intensity statin and non-users. At follow-up, high-intensity statin users exhibited a higher annual AVC accumulation compared to low-intensity statins and non-users. In a real-world scenario, high-intensity statin therapy was associated with a 30 % increased rate of hospitalization for non-rheumatic aortic valve disease. Our findings highlight the need for further investigation into the intricate relationship between statin therapy and aortic valve health to identify the optimal lipid-lowering strategy in the management of patients at risk of developing or afflicted by AS.
No takes yet. Share an insight, caveat, or question.
Myasoedova et al. (2025) conducted an observational in Aortic stenosis. High-intensity statins vs. Low-intensity statins and non-users was evaluated on Hospitalization for non-rheumatic aortic valve disease (30% increased rate). High-intensity statin therapy in aortic stenosis patients was associated with increased aortic valve calcification and a 30% increased rate of hospitalization for non-rheumatic aortic valve disease.
Synapse has enriched 10 related papers. Consider them for comparative context: